MedTrace Logo

Follow Up Study for Treatment of Parkinson's Disease With Subthalamic Deep Brain Stimulation

NCT03230331 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 20

Last updated 2020-03-11

No results posted yet for this study

Summary

This study aims to evaluate the long term effect of deep brain stimulation in the the subthalamic nucleus (STN) in patients with Parkinson's disease.

Conditions

  • Parkinson Disease

Sponsors & Collaborators

  • Ruijin Hospital

    lead OTHER

Principal Investigators

  • Haiyan Zhou · Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine

  • Dianyou Li · Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine

  • Bomin Sun · Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine

  • Wei Hu · University of Florida

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-07-24
Primary Completion
2019-05-01
Completion
2019-05-01

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03230331 on ClinicalTrials.gov